Lexicon Pharmaceuticals (NasdaqGS:LXRX) 2025 Conference Transcript
Lexicon Pharmaceuticals (NasdaqGS:LXRX) 2025 Conference November 18, 2025 12:00 PM ET Company ParticipantsCraig Granowitz - Chief Medical OfficerMike Exton - CEOConference Call ParticipantsAndrew Tsai - Senior Biotech AnalystAndrew TsaiThank you, everyone, for tuning in. I'm Andrew Tsai, Senior Biotech Analyst at Jefferies, and it's my pleasure to have the Lexicon team with me today. Sitting to the direct right of me is Craig Granowitz, CMO, and to his right is Mike Exton, CEO. Welcome, both of you.Maybe to ...